Designed to provide long-term central venous access via a subcutaneously implanted port for repeated administration of fluids and medications and for blood sampling.
Designed in collaboration with cardiologists to solve the most common challenges in radial hemostasis.
Vortex® technology's mode of action allows fluid to reach all surfaces in the port chamber, helping eliminate dead spaces, resist sludge build-up, and reduce occlusions.
Proprietary Endexo® technology provides a catheter material more resistant to the accumulation of blood components (platelets and thrombus).
Available in titanium standard, mini, and low profile configurations, as well as plastic.
SmartPort+® Implanted Ports give clinicians dependable, repeated vascular access for IV therapy, blood sampling, and power-injected Contrast-Enhanced CT (CECT) scanning. Featuring Vortex® and Endexo® technology to reduce the need for secondary interventions.
Speak to our team for more information, product details or support with your enquiry.
| Sterility | EO sterile |
| Legal Manufacturer | Angiodynamics, Inc. |
| Country of Origin | USA |
| Shelf Life/Expiry | 3 years |
| Customisation | Non-customisable |
| Regulatory Status | CE Marked |
There is no information to display.
